|
1
|
Rahbari R, Zhang L and Kebebew E: Thyroid
cancer gender disparity. Future Oncol. 6:1771–1779. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kilfoy BA, Devesa SS, Ward MH, et al:
Gender is an age-specific effect modifier for papillary cancers of
the thyroid gland. Cancer Epidemiol Biomarkers Prev. 18:1092–1100.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rajoria S, Suriano R, George AL, et al:
Estrogen activity as a preventive and therapeutic target in thyroid
cancer. Biomed Pharmacother. 66:151–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kansakar E, Chang YJ, Mehrabi M and Mittal
V: Expression of estrogen receptor, progesterone receptor, and
vascular endothelial growth factor-A in thyroid cancer. Am Surg.
75:785–789. 2009.PubMed/NCBI
|
|
6
|
Renoir JM, Marsaud V and Lazennec G:
Estrogen receptor signaling as a target for novel breast cancer
therapeutics. Biochem Pharmacol. 85:449–465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koos RD: Minireview: Putting physiology
back into estrogens' mechanism of action. Endocrinology.
152:4481–4488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Santin AP and Furlanetto TW: Role of
estrogen in thyroid function and growth regulation. J Thyroid Res.
2011:8751252011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kamat A, Rajoria S, George A, et al:
Estrogen-mediated angiogenesis in thyroid tumor microenvironment is
mediated through VEGF signaling pathways. Arch Otolaryngol Head
Neck Surg. 137:1146–1153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dong W, Zhang H, Li J, et al: Estrogen
induces metastatic potential of papillary thyroid cancer cells
through estrogen receptor alpha and beta. Int J Endocrinol.
2013:9415682013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lam KY, Lo CY and Leung PS: High
prevalence of RET protooncogene activation (RET/PTC) in papillary
thyroid carcinomas. Eur J Endocrinol. 147:741–745. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Croyle M, Akeno N, Knauf JA, et al:
RET/PTC-induced cell growth is mediated in part by epidermal growth
factor receptor (EGFR) activation: evidence for molecular and
functional interactions between RET and EGFR. Cancer Res.
68:4183–4191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wells A: EGF receptor. Int J Biochem Cell
Biol. 31:637–643. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sherman SI: Thyroid carcinoma. Lancet.
361:501–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lang BH, Lo CY, Chan WF, et al: Prognostic
factors in papillary and follicular thyroid carcinoma: their
implications for cancer staging. Ann Surg Oncol. 14:730–738. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eustatia-Rutten CF, Corssmit EP, Biermasz
NR, et al: Survival and death causes in differentiated thyroid
carcinoma. J Clin Endocrinol Metab. 91:313–319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
18
|
DeLellis RA and Williams ED: Tumours of
the thyroid and parathyroidWorld Health Organization Classification
of Tumours: Pathology and Genetics of Tumours of Endocrine Organs.
DeLellis RA, Lloyd RV, Heitz PU and Eng C: 3rd. IARC Press; Lyon:
pp. 562004
|
|
19
|
Huang Y, Dong W, Li J, Zhang H, Shan Z and
Teng W: Differential expression patterns and clinical significance
of estrogen receptor-α and β in papillary thyroid carcinoma. BMC
Cancer. 14:3832014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kavanagh DO, Mcllroy M, Myers E, et al:
The role of oestrogen receptor {alpha} in human thyroid cancer:
Contributions from coregulatory proteins and tyrosine kinase
receptor HER2. Endocr Relat Cancer. 17:255–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gorski J and Hou Q: Embryonic estrogen
receptors: do they have a physiological function? Environ Health
Perspect. 103 (Suppl 7):69–72. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weihua Z, Warner M and Gustafsson JA:
Estrogen receptor beta in the prostate. Mol Cell Endocrinol.
193:1–5. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen GG, Vlantis AC, Zeng Q, et al:
Regulation of cell growth by estrogen signaling and potential
targets in thyroid cancer. Curr Cancer Drug Targets. 8:367–377.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng Q, Chen G, Vlantis A, et al: The
contributions of oestrogen receptor isoforms to the development of
papillary and anaplastic thyroid carcinomas. J Pathol. 214:425–433.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng Q, Chen GG, Vlantis AC, et al:
Oestrogen mediates the growth of human thyroid carcinoma cells via
an oestrogen receptor-ERK pathway. Cell Prolif. 40:921–935. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee ML, Chen GG, Vlantis AC, et al:
Induction of thyroid papillary carcinoma cell proliferation by
estrogen is associated with an altered expression of Bcl-xL. Cancer
J. 11:113–121. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37 (Suppl 4):9–15. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van der Laan BF, Freeman JL and Asa SL:
Expression of growth factors and growth factor receptors in normal
and tumorous human thyroid tissues. Thyroid. 5:67–73. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duh QY, Siperstein AE, Miller RA, et al:
Epidermal growth factor receptors and adenylate cyclase activity in
human thyroid tissues. World J Surg. 14:410–417. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mizukami Y, Nonomura A, Hashimoto T, et
al: Immunohistochemical demonstration of epidermal growth factor
and c-myc oncogene product in normal, benign and malignant thyroid
tissues. Histopathology. 18:11–18. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Akslen LA, Myking AO, Salvesen H and
Varhaug JE: Prognostic impact of EGF-receptor in papillary thyroid
carcinoma. Br J Cancer. 68:808–812. 1993. View Article : Google Scholar : PubMed/NCBI
|
